» Articles » PMID: 3263843

Functional Abnormalities of Experimental Autogenous Vein Graft Neoendothelium

Overview
Journal Ann Surg
Specialty General Surgery
Date 1988 Nov 1
PMID 3263843
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

When a vein is grafted into the arterial circulation, the endothelium of the graft is damaged. Regeneration of an intact neoendothelium occurs, but the functional properties of this surface have not been clarified. In this study, the functional integrity of the neoendothelium of veins grafted into the carotid artery of the rabbit was assessed through the use of acetylcholine and histamine to stimulate the production of the important endothelium-derived relaxing factor (EDRF). Control veins, precontracted with norepinephrine [10(-5) M], relaxed after exposure to acetylcholine [( 10(-7) M], 42.4% +/- 6.4%, p = 0.008) and histamine [( 10(-6) M], 30.6% +/- 4.3%, p = 0.03). This relaxation response was abolished after mechanical removal of the endothelium. By contrast, neither acetylcholine nor histamine caused an endothelium-dependent relaxation in the vein grafts, even though scanning electron microscopy demonstrated the presence of a morphologically intact endothelium. However, addition of stabilized EDRF purified from cultured endothelial cells induced relaxation of the vein grafts (35.8% +/- 3.6%, p = 0.002). These data indicate that vein graft endothelium is unable to produce EDRF in response to exposure to acetylcholine or histamine. The inability to produce this potent smooth muscle cell relaxing factor and anti-aggregatory substance may be a predisposition to vein graft failure.

Citing Articles

Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts.

Mann M, Gibbons G, Tsao P, von der Leyen H, Cooke J, Buitrago R J Clin Invest. 1997; 99(6):1295-301.

PMID: 9077539 PMC: 507945. DOI: 10.1172/JCI119288.


The expression and function of G-proteins in experimental intimal hyperplasia.

Davies M, Ramkumar V, Gettys T, HAGEN P J Clin Invest. 1994; 94(4):1680-9.

PMID: 7929847 PMC: 295331. DOI: 10.1172/JCI117513.


[Neoangiogenesis in aneurysmatic autologous venous transplants].

KOGEL H, VOLLMAR J, Amselgruber W, Friese M Langenbecks Arch Chir. 1991; 376(1):23-6.

PMID: 1709712 DOI: 10.1007/BF00205123.

References
1.
Cambria R, Megerman J, Abbott W . Endothelial preservation in reversed and in situ autogenous vein grafts. A quantitative experimental study. Ann Surg. 1985; 202(1):50-5. PMC: 1250835. DOI: 10.1097/00000658-198507000-00007. View

2.
Alegria E, de la Morena G, Castello R, Barba J, Malpartida F . Methylergonovine-induced spasm of saphenous vein coronary bypass graft. Chest. 1985; 87(4):545-7. DOI: 10.1378/chest.87.4.545. View

3.
Verstraete M, Brown B, Chesebro J, EKESTROM S, Harker L, Henderson A . Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J. 1986; 7(1):4-13. DOI: 10.1093/oxfordjournals.eurheartj.a061955. View

4.
Gryglewski R, Palmer R, Moncada S . Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986; 320(6061):454-6. DOI: 10.1038/320454a0. View

5.
Zwolak R, Adams M, Clowes A . Kinetics of vein graft hyperplasia: association with tangential stress. J Vasc Surg. 1987; 5(1):126-36. View